American missionary survives Bundibugyo Ebola after Congo evacuation

Dr. Peter Stafford, an American missionary physician with Serge, is receiving specialized treatment in Berlin, Germany, after testing positive for the Bundibugyo ebolavirus. He was evacuated from the Democratic Republic of Congo on May 19, 2026, following his exposure to the virus while performing surgery at Nyankunde Hospital in Bunia.

A Medical Missionary’s Fight Against the Bundibugyo Virus

The path from a surgical suite in eastern Congo to a high-security isolation unit in Berlin has been harrowing for Dr. Peter Stafford. While serving with the international Christian missions organization Serge, Stafford contracted the Bundibugyo ebolavirus, a rare and deadly strain of the virus that has triggered a significant public health response in the Democratic Republic of Congo (DRC) and neighboring Uganda. Stafford’s condition, initially critical, appears to be stabilizing under the care of specialists at Charité University Hospital. Despite the severity of his illness, he has offered a glimmer of hope regarding his recovery.

Before I was evacuated I was feeling really concerned I wasn’t going to make it. And now I’m cautiously optimistic.

cluster (priority): Centers for Disease Control and Prevention | CDC (.gov)

Dr. Peter Stafford, via CBS News

Medical staff at the Berlin facility report that while Stafford remains severely weakened and requires close observation due to the unpredictable nature of the virus, he is not currently categorized as critically ill. He is being treated within a high-security area of the specialized isolation unit, where he has begun to tolerate small amounts of food, according to Dr. Scott Myhre, the Serge director for East and Central Africa.

The Scale of the Outbreak in Ituri Province

cluster (priority): Time Magazine

The outbreak that claimed Stafford’s health is the 17th recorded instance of Ebola in the DRC since the virus was first identified in 1976. According to the Centers for Disease Control and Prevention, the current surge was officially confirmed on May 15, 2026, in Ituri Province. The National Institute of Biomedical Research (INRB) identified the pathogen as the Bundibugyo virus, a strain known to carry a mortality rate ranging between 25% and 50%. The reality on the ground is rapidly outpacing early official counts. While initial reports from mid-May cited 246 suspected cases and 80 deaths, more recent data from the World Health Organization now suggests the crisis has expanded to nearly 750 suspected cases and 177 suspected deaths. The virus is circulating through regions marked by significant security challenges, including mining-related population displacement and frequent cross-border travel, which complicate containment efforts.

Quarantine Protocols for Family and Colleagues

Stafford’s evacuation was part of a larger, coordinated effort to remove high-risk contacts from the region. His wife, Dr. Rebekah Stafford, and their four children were also transported to Germany. They remain asymptomatic and are currently quarantined in a separate section of the isolation unit at Charité University Hospital. Other medical personnel who had contact with the virus are following strict monitoring protocols. Two additional physicians, including Dr. Patrick LaRochelle, were identified as having potential exposure. They are currently asymptomatic and are adhering to established quarantine guidelines. The evacuation process was described by officials as a necessary step to utilize an internationally recognized location for viral hemorrhagic fever treatments.

Travel Restrictions and International Response

cluster (priority): news.google.com

In response to the rising death toll and the potential for international spread, the CDC has implemented a 30-day restriction prohibiting non-U.S. citizens who have been in the DRC, Uganda, or South Sudan within the last 21 days from entering the United States. While the risk of spread to the U.S. is currently considered low, these measures reflect the gravity of the situation. As of late May 2026, there is no known vaccine or specific pharmaceutical treatment for the Bundibugyo strain. Clinical care remains focused on supportive measures, such as aggressive rehydration and symptom management. As the region continues to grapple with this outbreak, health officials emphasize that the situation remains fluid. Patients and those in affected areas are encouraged to monitor for symptoms such as fever, muscle pain, and vomiting, and to consult their healthcare provider if they have traveled to or worked in the impacted zones of the DRC or Uganda.